0,825  0,008  Caspase 9 stimulant
0,784  0,005  Aldehyde oxidase inhibitor
0,704  0,006  CTGF expression inhibitor
0,702  0,005  Histamine release inhibitor
0,678  0,005  5 Hydroxytryptamine release inhibitor
0,673  0,004  GABA C receptor rho-3 antagonist
0,664  0,017  Antileukemic
0,647  0,011  CYP1A2 substrate
0,638  0,019  GST A substrate
0,621  0,009  AR expression inhibitor
0,622  0,012  5 Hydroxytryptamine release stimulant
0,613  0,007  Antimutagenic
0,608  0,004  Peroxidase inhibitor
0,614  0,011  UGT1A9 substrate
0,627  0,044  Apoptosis agonist
0,574  0,011  Ulceration
0,575  0,017  Aryl hydrocarbon receptor agonist
0,553  0,004  Telomerase inhibitor
0,568  0,025  CYP2C9 substrate
0,552  0,011  FMO1 substrate
0,552  0,019  Antipruritic, allergic
0,542  0,009  Antineoplastic enhancer
0,539  0,013  Antiprotozoal (Leishmania)
0,529  0,006  Topoisomerase II inhibitor
0,562  0,042  Antineoplastic (breast cancer)
0,523  0,004  GST M1-1 substrate
0,528  0,010  Superoxide dismutase inhibitor
0,530  0,012  CYP1A2 inhibitor
0,529  0,016  NOS2 expression inhibitor
0,514  0,004  Pneumotoxic
0,540  0,038  Antineoplastic (lung cancer)
0,518  0,022  Antineoplastic (melanoma)
0,499  0,005  Breast cancer-resistant protein inhibitor
0,504  0,018  Antineoplastic (glioma)
0,502  0,022  Cardioprotectant
0,494  0,021  Caspase 3 stimulant
0,489  0,017  Free radical scavenger
0,498  0,029  Respiratory analeptic
0,503  0,035  Antineoplastic (colorectal cancer)
0,469  0,008  Carcinogenic, group 3
0,495  0,034  Antineoplastic (colon cancer)
0,483  0,022  NOS3 expression inhibitor
0,478  0,023  Antioxidant
0,455  0,004  Topoisomerase II alpha inhibitor
0,458  0,010  Antineoplastic (bladder cancer)
0,480  0,036  Prostate cancer treatment
0,464  0,023  Cardiovascular analeptic
0,446  0,009  UGT1A3 substrate
0,440  0,008  5 Hydroxytryptamine uptake stimulant
0,449  0,019  Amyloid beta aggregation inhibitor
0,433  0,006  UGT2B15 substrate
0,452  0,029  Antineoplastic (cervical cancer)
0,450  0,029  12-Lipoxygenase inhibitor
0,458  0,037  CYP2C19 inhibitor
0,445  0,024  Vasodilator, coronary
0,438  0,019  UGT1A6 substrate
0,467  0,049  15-Lipoxygenase inhibitor
0,451  0,034  CYP2C19 substrate
0,459  0,049  CYP3A4 substrate
0,431  0,023  Antineoplastic (glioblastoma multiforme)
0,434  0,029  Chemoprotective
0,418  0,015  UGT1A1 substrate
0,456  0,058  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,399  0,007  Acetylcholinesterase inhibitor
0,394  0,006  CYP2B6 inhibitor
0,397  0,012  MAO inhibitor
0,413  0,030  Antineoplastic (non-small cell lung cancer)
0,386  0,005  Cystathionine beta-synthase inhibitor
0,426  0,046  CYP2C9 inhibitor
0,381  0,005  Carcinogenic, group 1
0,381  0,006  Aldehyde dehydrogenase inhibitor
0,383  0,009  MAO A inhibitor
0,393  0,020  FMO3 substrate
0,402  0,029  Hypoxia-inducible factor 1 alpha inhibitor
0,428  0,058  Antiprotozoal
0,411  0,042  Antihypercholesterolemic
0,434  0,066  TNF expression inhibitor
0,386  0,020  Flavin-containing monooxygenase substrate
0,397  0,031  UGT2B4 substrate
0,406  0,043  Antineoplastic (ovarian cancer)
0,360  0,004  Antineoplastic (uterine cancer)
0,383  0,027  Antineoplastic (renal cancer)
0,372  0,019  UGT1A4 substrate
0,379  0,027  Antineoplastic (liver cancer)
0,370  0,019  P-glycoprotein inhibitor
0,363  0,013  Tyrosine 3 hydroxylase inhibitor
0,376  0,026  Pyruvate kinase inhibitor
0,380  0,033  Radiosensitizer
0,372  0,026  Transcription factor STAT inhibitor
0,390  0,046  CYP2D6 substrate
0,384  0,042  Analeptic
0,356  0,015  Antipruritic, non-allergic
0,402  0,063  Transcription factor NF kappa B inhibitor
0,350  0,012  NOS3 expression enhancer
0,372  0,035  DNA damaging
0,374  0,037  Cytostatic
0,372  0,035  Carcinogenic
0,352  0,018  Antihypotensive
0,379  0,045  Antineoplastic (brain cancer)
0,339  0,007  SULT1A3 substrate
0,346  0,014  Cholinergic
0,336  0,004  GABA C receptor rho-2 antagonist
0,338  0,008  Carcinogenic, group 2B
0,344  0,014  Genotoxic
0,373  0,046  Radioprotector
0,334  0,007  Succinate dehydrogenase inhibitor
0,348  0,021  Dual specificity phosphatase inhibitor
0,360  0,035  Mutagenic
0,347  0,024  RNA-directed DNA polymerase inhibitor
0,337  0,014  Acaricide
0,362  0,040  Sensitization
0,367  0,046  Lipoxygenase inhibitor
0,334  0,015  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,344  0,027  UDP-glucuronosyltransferase substrate
0,351  0,034  Chemopreventive
0,365  0,048  Spasmolytic
0,342  0,026  Antineoplastic (sarcoma)
0,353  0,039  Antiprotozoal (Trypanosoma)
0,318  0,004  Carcinogenic, group 2A
0,325  0,014  Alpha-N-acetylglucosaminidase inhibitor
0,315  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,350  0,039  Antihypoxic
0,348  0,038  Cardiodepressant
0,317  0,007  Carbonic anhydrase XV inhibitor
0,323  0,014  GST P1-1 substrate
0,343  0,034  Antiparasitic
0,393  0,086  Calcium channel L-type activator
0,313  0,012  MAO B inhibitor
0,366  0,065  Antiprotozoal (Plasmodium)
0,311  0,011  NADPH oxidase inhibitor
0,309  0,010  Butyrylcholinesterase inhibitor
0,338  0,039  Insulysin inhibitor
0,339  0,042  Proliferative diseases treatment
0,315  0,020  Melanin inhibitor
0,345  0,053  Calcium channel activator
0,312  0,024  UGT2B7 substrate
0,327  0,041  Transcription factor STAT3 inhibitor
0,295  0,010  Antiprotozoal (Coccidial)
0,294  0,008  Excitatory amino acid transporter EAAC1 inhibitor
0,331  0,046  Antineoplastic (small cell lung cancer)
0,288  0,005  VEGF expression inhibitor
0,310  0,027  Dual specificity phosphatase 3 inhibitor
0,304  0,022  Antiseptic
0,286  0,004  Creatine kinase inhibitor
0,296  0,016  I kappa B kinase epsilon inhibitor
0,284  0,006  Carbonic anhydrase III inhibitor
0,358  0,080  Prostaglandin dehydrogenase inhibitor
0,282  0,007  5 Hydroxytryptamine 3E antagonist
0,393  0,118  Alpha-glucosidase inhibitor
0,285  0,012  Antiviral (West Nile virus)
0,303  0,031  Gastrin inhibitor
0,286  0,015  Nitric-oxide synthase stimulant
0,320  0,050  Antipyretic
0,344  0,076  Vasodilator, peripheral
0,275  0,008  Mannose-6-phosphate isomerase inhibitor
0,280  0,013  Aldehyde oxidase substrate
0,287  0,020  Muscular dystrophy treatment
0,269  0,004  CYP2A6 inhibitor
0,300  0,036  Antiparkinsonian, rigidity relieving
0,360  0,096  Antibacterial
0,308  0,045  Vasodilator
0,321  0,057  Teratogen
0,266  0,004  Multidrug resistance-associated protein 1 inhibitor
0,322  0,060  Antineoplastic (pancreatic cancer)
0,282  0,022  Skin whitener
0,293  0,033  Antihelmintic
0,327  0,068  Apoptosis antagonist
0,267  0,008  SULT1A1 substrate
0,297  0,041  Nitric oxide antagonist
0,263  0,008  Carbonic anhydrase VI inhibitor
0,260  0,005  Antirickettsial
0,291  0,037  Platelet adhesion inhibitor
0,263  0,010  Phobic disorders treatment
0,258  0,006  Antiprotozoal (Babesia)
0,254  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,261  0,012  Antihemorrhagic
0,254  0,005  Antihelmintic (Trematoda)
0,268  0,020  3C-like protease (Human coronavirus) inhibitor
0,262  0,015  Topoisomerase I inhibitor
0,253  0,013  GABA C receptor agonist
0,249  0,010  Antischistosomal
0,268  0,029  Neurotrophic factor enhancer
0,254  0,015  5-Lipoxygenase inhibitor
0,257  0,019  Alkaline phosphatase inhibitor
0,254  0,016  DNA intercalator
0,295  0,060  Embryotoxic
0,259  0,026  Amylase inhibitor
0,240  0,007  Photosensitizer
0,257  0,025  Protein kinase stimulant
0,255  0,024  Bone formation stimulant
0,244  0,013  Xanthine oxidase inhibitor
0,244  0,014  UDP-glucose 4-epimerase inhibitor
0,286  0,056  Antiamyloidogenic
0,255  0,026  Antiparkinsonian, tremor relieving
0,257  0,029  Protein-tyrosine phosphatase inhibitor
0,236  0,010  Carbonic anhydrase XIII inhibitor
0,228  0,005  GABA C receptor rho-1 antagonist
0,263  0,040  Hepatoprotectant
0,321  0,102  Calpain 2 inhibitor
0,258  0,040  Non-steroidal antiinflammatory agent
0,260  0,042  DNA methyltransferase I inhibitor
0,259  0,042  VCAM1 expression inhibitor
0,296  0,080  Antimycobacterial
0,271  0,055  DNA synthesis inhibitor
0,277  0,061  Interleukin agonist
0,296  0,080  Streptokinase A inhibitor
0,234  0,018  UGT2B10 substrate
0,242  0,027  Phospholipase C inhibitor
0,217  0,004  Antidote, mercury
0,268  0,055  Cyclic AMP phosphodiesterase inhibitor
0,221  0,009  GABA C receptor antagonist
0,215  0,005  DOPA decarboxylase inhibitor
0,263  0,054  Psychostimulant
0,229  0,021  Aldose reductase substrate
0,323  0,115  MAP kinase kinase 6 inhibitor
0,254  0,046  DNA methylase inhibitor
0,226  0,019  Gout treatment
0,227  0,023  Antifungal enhancer
0,242  0,039  Mcl-1 antagonist
0,230  0,027  UGT2B9 substrate
0,233  0,030  CNS active muscle relaxant
0,207  0,004  Protease activated receptor antagonist
0,219  0,018  Arachidonic acid antagonist
0,205  0,005  GST T1-1 substrate
0,225  0,026  Antineoplastic (bone cancer)
0,240  0,042  MAP kinase kinase 3 inhibitor
0,208  0,010  Protein kinase C zeta inhibitor
0,217  0,019  Ferrochelatase inhibitor
0,235  0,038  Antianorexic
0,209  0,013  5 Hydroxytryptamine 3A agonist
0,269  0,073  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,229  0,033  Interferon gamma antagonist
0,292  0,096  Cholesterol antagonist
0,210  0,015  Movement disorders treatment
0,234  0,039  Amyloid beta precursor protein antagonist
0,243  0,050  Antialcoholic
0,221  0,028  Monophenol monooxygenase inhibitor
0,259  0,066  5 Hydroxytryptamine 1E antagonist
0,210  0,017  CF transmembrane conductance regulator agonist
0,218  0,025  ATPase inhibitor
0,203  0,013  Histidine decarboxylase inhibitor
0,199  0,009  DNA repair enzyme inhibitor
0,273  0,083  Antineoplastic (multiple myeloma)
0,195  0,005  Interleukin 5 antagonist
0,220  0,031  Cytokine production inhibitor
0,198  0,010  Sphingomyelinase inhibitor
0,198  0,011  Antiviral (Influenza B)
0,239  0,051  Abortion inducer
0,194  0,007  Heat shock protein 70 antagonist
0,213  0,026  Death-associated protein kinase 2 inhibitor
0,194  0,009  Electron transport complex I inhibitor
0,275  0,091  Antineoplastic (osteosarcoma)
0,194  0,011  Triose-phosphate isomerase inhibitor
0,221  0,038  Heat shock protein 90 alpha antagonist
0,191  0,011  Sphingosine 1-phosphate receptor 4 antagonist
0,215  0,037  Antiviral (Ebola)
0,191  0,013  Porphobilinogen synthase inhibitor
0,237  0,060  MAP kinase kinase 2 inhibitor
0,192  0,016  NAT2 substrate
0,192  0,016  Mediator release inhibitor
0,279  0,104  Antithrombotic
0,189  0,014  Uric acid excretion stimulant
0,181  0,007  Ca2+-transporting ATPase inhibitor
0,182  0,007  NAT1 substrate
0,183  0,009  Macrophage migration inhibitory factor inhibitor
0,189  0,015  Antihelmintic (Fasciola)
0,232  0,059  Anesthetic general
0,208  0,035  Tubulin antagonist
0,201  0,029  Protein-tyrosine phosphatase 1B inhibitor
0,216  0,046  Eye irritation, high
0,269  0,100  CYP3A4 inhibitor
0,181  0,012  Antiviral (Papilloma)
0,175  0,007  Acetylcholine release stimulant
0,195  0,027  Glutathione S-transferase substrate
0,175  0,008  Alcohol oxidase inhibitor
0,181  0,015  Arylamine N-Acetyltransferase substrate
0,185  0,021  MAP kinase kinase 4 inhibitor
0,183  0,018  Potassium channel (Ca-activated) activator
0,168  0,005  DNA-dependent protein kinase inhibitor
0,185  0,022  Adenylate cyclase stimulant
0,189  0,028  Adenylate cyclase inhibitor
0,237  0,077  Calpain inhibitor
0,170  0,009  Antifungal (Pneumocystis)
0,177  0,017  TRPA1 agonist
0,212  0,053  Histone acetyltransferase inhibitor
0,169  0,011  Aromatase inhibitor
0,182  0,024  Hearing loss treatment
0,168  0,010  Postmenopausal disorders treatment
0,175  0,017  Antispirochetal
0,179  0,022  Coagulant
0,187  0,030  Toll-Like receptor 2 antagonist
0,164  0,009  Antiviral (Rhinovirus)
0,165  0,011  SULT1E1 substrate
0,237  0,085  Hypoglycemic
0,213  0,061  Insulin sensitizer
0,170  0,018  Beta glucuronidase inhibitor
0,154  0,003  Glutamate (mGluR7) antagonist
0,193  0,042  Heat shock protein 90 antagonist
0,194  0,044  Cyclooxygenase inhibitor
0,171  0,021  Antineoplastic, alkylator
0,179  0,029  Protein kinase (CK2) alpha inhibitor
0,195  0,046  Antiviral (Influenza A)
0,192  0,043  Antidote
0,169  0,022  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,157  0,010  Aldose reductase inhibitor
0,165  0,019  Estrogen antagonist
0,154  0,008  Carbonic anhydrase VB inhibitor
0,307  0,162  DNA polymerase beta inhibitor
0,166  0,021  Adenylate kinase inhibitor
0,172  0,028  Beta amyloid protein antagonist
0,167  0,023  Sulfotransferase substrate
0,158  0,014  Estrogen receptor beta antagonist
0,161  0,018  Alcohol dehydrogenase inhibitor
0,164  0,021  HIV-1 integrase (Overall Integration) inhibitor
0,147  0,005  Topoisomerase II beta inhibitor
0,215  0,072  Cytotoxic
0,173  0,033  Antiprotozoal (Trichomonas)
0,158  0,018  Transcription factor STAT6 inhibitor
0,174  0,034  Cholesterol synthesis inhibitor
0,249  0,110  Antifungal
0,195  0,056  Tumour necrosis factor antagonist
0,184  0,047  Antineoplastic (squamous cell carcinoma)
0,145  0,009  mTOR complex 2 inhibitor
0,162  0,026  Mucolytic
0,195  0,059  Muscle relaxant
0,218  0,082  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,193  0,057  Antineoplastic (gastric cancer)
0,249  0,114  Bone diseases treatment
0,140  0,005  Aryl hydrocarbon receptor antagonist
0,175  0,040  Cyclooxygenase 2 inhibitor
0,151  0,017  NADH dehydrogenase inhibitor
0,168  0,034  Cyclooxygenase 3 inhibitor
0,178  0,044  Cyclooxygenase 1 inhibitor
0,147  0,013  Glutamate (mGluR7) agonist
0,162  0,028  Protein kinase (CK2) inhibitor
0,182  0,048  Hexokinase inhibitor
0,159  0,028  Contraceptive female
0,253  0,122  Thyroid hormone antagonist
0,166  0,035  Antibacterial (Helicobacter pylori)
0,233  0,102  Antituberculosic
0,180  0,050  Lipid peroxidase inhibitor
0,135  0,006  CD45 antagonist
0,137  0,009  Purinergic P2X1 antagonist
0,132  0,004  GABA B receptor antagonist
0,163  0,036  Antiprotozoal (Amoeba)
0,139  0,011  Thioredoxin reductase inhibitor
0,143  0,016  Carbonic anhydrase V inhibitor
0,142  0,016  Keratolytic
0,179  0,053  Uterine stimulant
0,174  0,049  Toll-Like receptor 9 antagonist
0,139  0,015  HIV-1 integrase (3'-Processing) inhibitor
0,218  0,095  Vascular (periferal) disease treatment
0,173  0,051  Skeletal muscle relaxant
0,176  0,054  Antineoplastic (carcinoma)
0,216  0,094  Neuropeptide Y2 antagonist
0,162  0,040  Interleukin 4 antagonist
0,131  0,009  D-Ala-D-Ala ligase inhibitor
0,136  0,014  Estrogen receptor alpha antagonist
0,154  0,034  Gastritis treatment
0,125  0,005  Antidote, organophosphates
0,247  0,127  ICAM1 expression inhibitor
0,243  0,123  Thyroid hormone beta antagonist
0,140  0,020  UGT2B11 substrate
0,122  0,003  Glutamate (mGluR1a) agonist
0,122  0,003  Dopamine D5 agonist
0,162  0,043  Sphingosine 1-phosphate receptor 5 antagonist
0,148  0,030  UGT2B1 substrate
0,132  0,015  Carbonic anhydrase VA inhibitor
0,159  0,042  Alkylator
0,163  0,046  M18 aspartyl aminopeptidase inhibitor
0,234  0,118  CYP2D6 inhibitor
0,151  0,035  Expectorant
0,130  0,014  Interferon agonist
0,131  0,015  Beta tubulin antagonist
0,126  0,011  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,285  0,170  DNA directed DNA polymerase inhibitor
0,199  0,084  Antihypertriglyceridemic
0,118  0,004  Antihemophilic
0,132  0,018  Ornithine decarboxylase inhibitor
0,139  0,027  Antiprotozoal (Toxoplasma)
0,138  0,027  Calcium antagonist
0,125  0,013  Granulocyte macrophage colony stimulating factor agonist
0,202  0,092  Antineoplastic (lymphoma)
0,116  0,006  Glutamate (mGluR6) antagonist
0,136  0,026  Anabolic
0,120  0,011  Xanthine dehydrogenase inhibitor
0,138  0,030  Urease inhibitor
0,115  0,007  Aldosterone antagonist
0,162  0,054  Cell wall synthesis inhibitor
0,153  0,046  Skin irritative effect
0,119  0,013  Protein kinase C eta inhibitor
0,181  0,075  Antiviral (Hepatitis)
0,208  0,102  Tumour necrosis factor alpha release inhibitor
0,158  0,053  Neurotrophic factor
0,128  0,023  Phosphofructokinase-1 inhibitor
0,202  0,097  Dyrk kinase inhibitor
0,126  0,022  Antifungal (Aspergillus)
0,112  0,008  Fatty acid synthase inhibitor
0,120  0,016  GABA aminotransferase inhibitor
0,179  0,075  LDLR expression enhancer
0,130  0,027  Actinic keratosis treatment
0,122  0,019  Myeloperoxidase inhibitor
0,273  0,171  Transcription factor inhibitor
0,166  0,064  Diuretic
0,107  0,005  Transcription factor RelA inhibitor
0,112  0,011  NMDA receptor glycine site agonist
0,120  0,021  Glutamate decarboxylase inhibitor
0,146  0,047  Sphingosine 1-phosphate receptor 2 antagonist
0,181  0,082  Sedative
0,102  0,004  Adenylate cyclase 1 inhibitor
0,105  0,007  Potassium channel Kv1.3 blocker
0,128  0,030  Electrolyte absorption antagonist
0,165  0,068  Cystic fibrosis treatment
0,138  0,043  Aminopeptidase B inhibitor
0,118  0,023  Glutamate dehydrogenase inhibitor
0,157  0,063  Thiol protease inhibitor
0,137  0,042  Shock treatment
0,125  0,031  Androgen antagonist
0,123  0,029  Thioredoxin inhibitor
0,150  0,057  Interleukin 1 antagonist
0,126  0,034  Prolactin inhibitor
0,100  0,008  Aconitate hydratase inhibitor
0,194  0,103  Antineoplastic (lymphocytic leukemia)
0,095  0,005  Purinergic P2X4 antagonist
0,093  0,003  Vanilloid 3 antagonist
0,104  0,015  Antidote, heavy metal
0,116  0,028  Antiviral (Trachoma)
0,116  0,029  Phosphodiesterase 6D inhibitor
0,107  0,020  HIV-1 integrase (Strand Transfer) inhibitor
0,092  0,005  Ryanodine receptor antagonist
0,104  0,018  Acetylcholine M5 receptor agonist
0,109  0,023  Histone deacetylase stimulant
0,109  0,023  Histone deacetylase SIRT1 stimulant
0,096  0,011  SULT2A1 substrate
0,140  0,054  Cathepsin H inhibitor
0,260  0,175  Antiparkinsonian
0,106  0,021  Potassium channel large-conductance Ca-activated activator
0,106  0,022  Caspase 7 inhibitor
0,127  0,044  AMP-activated protein kinase stimulant
0,140  0,057  Antihyperlipoproteinemic
0,140  0,058  Retinoprotector
0,101  0,019  Argininosuccinate synthase inhibitor
0,093  0,011  Potassium channel intermediate-conductance Ca-activated blocker
0,201  0,119  Immunostimulant
0,116  0,035  Potassium channel activator
0,159  0,077  Antiviral (Hepatitis C)
0,160  0,079  Neurotensin receptor agonist
0,088  0,008  Anesthetic inhalation
0,193  0,113  MAP-kinase-activated kinase 5 inhibitor
0,100  0,020  Phosphodiesterase VI inhibitor
0,091  0,014  Heat shock protein 90 beta antagonist
0,091  0,014  Exportin-1 inhibitor
0,113  0,037  mTOR complex 1 inhibitor
0,128  0,052  Microtubule formation inhibitor
0,107  0,031  Cathepsin G inhibitor
0,094  0,018  S-adenosyl-L-methionine decarboxylase inhibitor
0,100  0,025  Phenylalanine 4-hydroxylase inhibitor
0,091  0,016  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,101  0,027  CDC25A inhibitor
0,124  0,050  Chelator
0,107  0,033  Glutamate release inhibitor
0,079  0,005  Sirtuin 2 inhibitor
0,090  0,017  Interferon inducer
0,095  0,021  NMDA receptor agonist
0,095  0,022  Carbamoyl phosphate synthetase inhibitor
0,099  0,026  Estrogen-related receptor beta agonist
0,093  0,020  MAP kinase kinase 7 inhibitor
0,099  0,029  Cyclin B3 inhibitor
0,153  0,083  Antihelmintic (Nematodes)
0,090  0,020  TRPA1 antagonist
0,091  0,021  Biliverdin reductase inhibitor
0,087  0,018  Antiviral (Parainfluenza)
0,141  0,072  Pregnane X receptor agonist
0,107  0,039  Antifungal (Candida)
0,090  0,022  Phospholipase D inhibitor
0,092  0,024  Vanilloid 4 agonist
0,074  0,006  Cytokine production stimulant
0,123  0,055  Caspase 3 inhibitor
0,081  0,013  Postcoital contraceptive
0,142  0,074  Hair growth stimulant
0,160  0,092  Lipocortins synthesis antagonist
0,169  0,102  Focal adhesion kinase 2 inhibitor
0,079  0,013  Glutamate (mGluR group I) agonist
0,088  0,022  Protease 3C (Human rhinovirus) inhibitor
0,120  0,055  Nav1.5 sodium channel blocker
0,142  0,077  Antianemic
0,069  0,005  Delayed rectifier potassium channel blocker
0,074  0,010  Potassium channel (Inward rectifier) activator
0,107  0,043  Antineoplastic antibiotic
0,098  0,034  Glycine receptor antagonist
0,108  0,045  Lanosterol 14 alpha demethylase inhibitor
0,067  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,071  0,009  Retinoid X alpha receptor agonist
0,073  0,011  Glucose-6-phosphate isomerase inhibitor
0,071  0,009  Potassium channel (ATP-sensitive) activator
0,071  0,010  Cholesterol esterase inhibitor
0,070  0,009  Glutamate (mGluR group III) antagonist
0,121  0,060  Interleukin 8 antagonist
0,103  0,043  Histamine N-methyltransferase inhibitor
0,100  0,040  Bromodomain-containing protein 2 inhibitor
0,093  0,033  T cell inhibitor
0,068  0,008  Antihyperaldosteronism
0,067  0,008  DNA gyrase subunit A inhibitor
0,101  0,043  Restless leg syndrome treatment
0,090  0,033  Narcotic antagonist
0,097  0,040  Inducible nitric-oxide synthase inhibitor
0,079  0,023  Acyl-CoA dehydrogenase inhibitor
0,087  0,031  Glycine receptor agonist
0,079  0,023  Antimycoplasmal
0,070  0,014  Leukotriene C antagonist
0,083  0,027  Protein kinase C beta inhibitor
0,077  0,021  Cyclin D1 inhibitor
0,065  0,009  Inosine monophosphate dehydrogenase inhibitor
0,106  0,050  Interleukin 1 beta converting enzyme inhibitor
0,112  0,056  Antiviral (Poxvirus)
0,086  0,031  GABA B receptor agonist
0,085  0,030  Secretase beta inhibitor
0,059  0,005  Protein kinase (CK2) beta inhibitor
0,058  0,004  Imidazoline I1 receptor antagonist
0,092  0,039  Na+ K+ transporting ATPase inhibitor
0,083  0,030  Leukotriene antagonist
0,069  0,016  Pregnane X receptor antagonist
0,070  0,017  Dihydroorotate oxidase inhibitor
0,119  0,066  Proteasome inhibitor
0,067  0,016  Carbonic anhydrase VII inhibitor
0,087  0,036  Aminopeptidase I inhibitor
0,157  0,108  Antiviral (Influenza)
0,084  0,035  MAP3K7 inhibitor
0,065  0,016  Heparanase inhibitor
0,081  0,033  Bulimia treatment
0,075  0,027  MDM2 inhibitor
0,134  0,087  MAP3K9 inhibitor
0,135  0,087  Cytidine deaminase inhibitor
0,281  0,233  Antiinflammatory
0,060  0,014  Retinoid X receptor agonist
0,109  0,063  Choleretic
0,107  0,060  Alpha 2c adrenoreceptor antagonist
0,138  0,091  Raynaud's phenomenon treatment
0,055  0,009  Glutamate (mGluR8) agonist
0,051  0,005  Glutamate (mGluR1) agonist
0,112  0,066  Mental retardation treatment
0,070  0,026  GABA receptor antagonist
0,093  0,049  Tocolytic
0,067  0,024  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,065  0,022  Carbonic anhydrase XIV inhibitor
0,071  0,030  Androgen agonist
0,065  0,023  Leukotriene B4 antagonist
0,079  0,038  HIV-1 integrase inhibitor
0,056  0,015  Guanylate cyclase inhibitor
0,081  0,042  Cushing's syndrome treatment
0,051  0,012  MAP3K5 inhibitor
0,048  0,009  ATP citrate lysase inhibitor
0,066  0,027  Alpha tubulin antagonist
0,081  0,042  Adenosine A3 receptor antagonist
0,122  0,083  Contraceptive
0,080  0,041  Phosphodiesterase V inhibitor
0,057  0,019  Fructose-1,6-bisphosphatase inhibitor
0,053  0,015  Nerve growth factor antagonist
0,077  0,039  Leukotriene synthesis inhibitor
0,133  0,095  Phospholipase A2 inhibitor
0,051  0,014  Retinoic acid alpha receptor agonist
0,057  0,019  Cathepsin L2 inhibitor
0,089  0,052  Sodium/hydrogen exchanger 5 inhibitor
0,180  0,143  Antiosteoporotic
0,070  0,033  Adenosine A1 receptor antagonist
0,057  0,021  Estradiol 17 beta-dehydrogenase inhibitor
0,121  0,086  Vanilloid 1 agonist
0,071  0,036  CDC25B inhibitor
0,050  0,015  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,049  0,014  Potassium channel Kv1.1 blocker
0,086  0,052  Glutathione S-transferase inhibitor
0,105  0,070  Alpha 2b adrenoreceptor antagonist
0,109  0,074  Antitussive
0,140  0,106  Antipruritic
0,204  0,169  Thioredoxin glutathione reductase inhibitor
0,047  0,013  Leukotriene C4 antagonist
0,051  0,018  Histamine H1 receptor agonist
0,144  0,111  Cyclin-dependent kinase 3 inhibitor
0,073  0,040  Endocannabinoid uptake inhibitor
0,134  0,101  Neuropathy treatment
0,047  0,014  Glutamate (mGluR3) antagonist
0,052  0,019  Glutamate (mGluR4) antagonist
0,098  0,066  Chronic obstructive bronchitis treatment
0,069  0,037  5 Hydroxytryptamine 3 agonist
0,086  0,054  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,249  0,217  Alzheimer's disease treatment
0,067  0,035  Calcium channel P-type blocker
0,090  0,058  Pim-3 kinase inhibitor
0,256  0,226  MAP kinase 1 inhibitor
0,073  0,042  Anticholelithogenic
0,059  0,029  DNA helicase inhibitor
0,096  0,066  Nitric-oxide synthase inhibitor
0,033  0,003  Imidazoline I2 receptor antagonist
0,052  0,023  Benzodiazepine antagonist
0,042  0,012  Nucleoside transporters inhibitor
0,063  0,034  Sphingosine kinase inhibitor
0,094  0,065  MAP kinase kinase 1 inhibitor
0,109  0,080  Histone deacetylase class III inhibitor
0,102  0,074  CDC-like kinase 3 inhibitor
0,058  0,029  Immunoglobulin Fc receptor antagonist
0,067  0,039  Beta 3 adrenoreceptor antagonist
0,045  0,017  Retinoid X receptor antagonist
0,047  0,019  Progesterone antagonist
0,068  0,040  Hyperparathyroidism treatment
0,047  0,020  Estrogen receptor beta agonist
0,068  0,041  Uterine relaxant
0,099  0,072  Factor V inhibitor
0,038  0,011  Protein kinase C beta I inhibitor
0,067  0,040  5 Hydroxytryptamine 2A agonist
0,077  0,050  Acetylcholine M4 receptor antagonist
0,058  0,032  GABA A receptor antagonist
0,059  0,033  Carbonic anhydrase XII inhibitor
0,080  0,055  Xanthine oxidase substrate
0,040  0,015  Retinoid X alpha receptor antagonist
0,050  0,025  Antiviral (Enterovirus)
0,126  0,102  Hemostatic
0,042  0,017  Fumarate hydratase inhibitor
0,049  0,024  Leukocyte elastase inhibitor
0,033  0,008  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,046  0,022  Heme oxygenase inhibitor
0,028  0,004  Vesicular glutamate transport inhibitor
0,045  0,021  Alpha 1d adrenoreceptor agonist
0,088  0,065  Paget's disease treatment
0,028  0,005  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,040  0,017  Glutamate (mGluR8) antagonist
0,038  0,015  Melatonin receptor 1A agonist
0,033  0,010  Nicotinic acid receptor 2 antagonist
0,064  0,041  Adenosine A2a receptor antagonist
0,036  0,014  Glutamate (mGluR3) agonist
0,069  0,046  Sirtuin 1 inhibitor
0,045  0,023  Thymidine kinase inhibitor
0,044  0,022  Kainate receptor agonist
0,054  0,033  Estrogen agonist
0,051  0,030  Antiviral (Herpesvirus 3, Human)
0,119  0,098  Nav1.6 sodium channel blocker
0,146  0,125  Angiogenesis stimulant
0,061  0,041  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,055  0,035  Alpha-mannosidase inhibitor
0,091  0,071  Bile acid receptor antagonist
0,036  0,017  Cholesterol ester transfer protein antagonist
0,072  0,053  Catalase inhibitor
0,051  0,032  Squalene epoxidase inhibitor
0,081  0,062  CC chemokine 5 receptor agonist
0,024  0,006  Antibiotic Anthracycline-like
0,037  0,019  Free fatty acid receptor 1 antagonist
0,090  0,072  Anticataract
0,061  0,043  Corticotropin releasing factor 2 receptor antagonist
0,031  0,013  Dopamine autoreceptor agonist
0,047  0,029  Glutamate (mGluR5) agonist
0,049  0,032  Dopamine beta hydroxylase inhibitor
0,026  0,009  Inosine monophosphate dehydrogenase 2 inhibitor
0,099  0,082  Interleukin 1b antagonist
0,036  0,020  Purinergic P2Y2 antagonist
0,059  0,043  Alpha 2 adrenoreceptor agonist
0,039  0,023  Arginase inhibitor
0,108  0,093  Anesthetic
0,060  0,045  Narcolepsy treatment
0,044  0,029  Histamine H2 receptor agonist
0,040  0,026  GABA uptake inhibitor
0,061  0,047  Adenosine A2 receptor antagonist
0,028  0,013  Acid ceramidase inhibitor
0,128  0,113  MAP kinase 3 inhibitor
0,092  0,078  Falcipain 3 inhibitor
0,038  0,024  Integrin alpha2 antagonist
0,113  0,100  Histone deacetylase SIRT1 inhibitor
0,069  0,057  Orexin receptor 1 antagonist
0,018  0,005  Antibiotic Tetracycline-like
0,031  0,018  DNA topoisomerase IV inhibitor
0,028  0,016  Integrin alpha2beta1 antagonist
0,025  0,013  Estrone sulfatase inhibitor
0,102  0,090  Myasthenia Gravis treatment
0,121  0,109  Insulin secretagoues
0,026  0,015  Vanilloid 2 agonist
0,033  0,022  Estrogen-related receptor beta antagonist
0,032  0,022  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,052  0,041  Carbonic anhydrase IX inhibitor
0,040  0,030  Liver X receptor alpha agonist
0,043  0,033  Oleamide hydrolase inhibitor
0,015  0,005  Melatonin 2 antagonist
0,068  0,058  Peroxisome proliferator-activated receptor gamma antagonist
0,014  0,004  Progesterone receptor A antagonist
0,027  0,017  Sodium/glucose cotransporter 2 inhibitor
0,023  0,014  GRP78 expression inhibitor
0,038  0,029  Urate transporter 1 inhibitor
0,021  0,013  Retinoid X beta receptor antagonist
0,057  0,049  Carbonic anhydrase inhibitor
0,024  0,015  Fructose-1,6-bisphosphatase 1 inhibitor
0,039  0,031  CF transmembrane conductance regulator antagonist
0,078  0,070  Transforming growth factor beta 3 antagonist
0,030  0,022  Epoxide hydrolase 1 inhibitor
0,047  0,040  Lysophosphatidic acid 3 receptor antagonist
0,023  0,015  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,027  0,020  Glucosylceramidase stimulant
0,025  0,018  Complement factor 1s inhibitor
0,028  0,021  Purinergic P2Y15 antagonist
0,065  0,058  Benzodiazepine agonist
0,035  0,028  ATM kinase inhibitor
0,171  0,165  Amyotrophic lateral sclerosis treatment
0,100  0,093  Antineoplastic antimetabolite
0,066  0,060  Antibiotic
0,023  0,018  Protein 30S ribosomal subunit inhibitor
0,050  0,044  Nicotinic alpha3beta2 receptor antagonist
0,042  0,037  Mannosidase inhibitor
0,017  0,012  Telomerase stimulant
0,026  0,021  Uridine phosphorylase inhibitor
0,020  0,016  Neuraminidase (Influenza B) inhibitor
0,020  0,016  Excitatory amino acid transporter 3 inhibitor
0,027  0,024  Estrogen-related receptor gamma antagonist
0,059  0,056  Sphingosine 1-phosphate receptor 4 agonist
0,024  0,021  Sodium/glucose cotransporter inhibitor
0,039  0,036  Cholesterol absorption inhibitor
0,045  0,042  HCV NS3/NS4A protease inhibitor
0,019  0,016  Antibiotic Quinolone-like
0,068  0,065  Nicotinic alpha4beta2 receptor antagonist
0,093  0,090  Anesthetic local
0,026  0,024  Hedgehog signaling activator
0,017  0,016  Alpha 2c adrenoreceptor agonist
0,051  0,050  Cathepsin L inhibitor
0,059  0,058  Beta adrenoreceptor antagonist
0,014  0,014  NMDA receptor phencyclidine site antagonist

